Download PDF
Exp Clin Endocrinol Diabetes 2019; 127(01): 23-28
DOI: 10.1055/a-0669-9309
Article
© Georg Thieme Verlag KG Stuttgart · New York

The Relationship Between Statin Action On Thyroid Autoimmunity And Vitamin D Status: A Pilot Study

Robert Krysiak
1   Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland
,
Witold Szkróbka
1   Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland
,
Bogusław Okopień
1   Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland
› Author Affiliations
Further Information

Publication History

received 02 May 2018
revised 26 July 2018

accepted 06 August 2018

Publication Date:
27 August 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Background Both vitamin D preparations and high-dose statin therapy were found to reduce thyroid antibody titers.

Objective The purpose of this study was to assess whether vitamin D status determines the effect of statin therapy on thyroid autoimmunity.

Methods The study population consisted of 39 euthyroid women with Hashimoto's thyroiditis and moderate or moderately high cardiovascular risk divided into two groups: women with vitamin D deficiency or insufficiency (group A; n=19) and women with normal vitamin D status (group B, n=20). All patients received atorvastatin therapy (20–40 mg daily) for the following 6 months. Plasma lipids, circulating levels of thyrotropin, free thyroid hormones, prolactin and 25-hydroxyvitamin D, titers of thyroid peroxidase and thyroglobulin antibodies, as well as Jostel’s, the SPINA-GT and the SPINA-GD indices were assessed at the beginning and at the end of the study.

Results The study completed all women. At baseline, with the exception of 25-hydroxyvitamin D, there were no significant differences between both study groups in plasma lipids, circulating hormone levels and titers of thyroid peroxidase and thyroglobulin antibodies. Despite improving plasma lipids in both study groups, atorvastatin reduced thyroid antibody titers only in women with normal vitamin D status. Moreover, in this group of patients, atorvastatin increased the SPINA-GT index. Circulating levels of the measured hormones, Jostel’s thyrotropin index and the SPINA-GD index remained at a similar level throughout the study.

Conclusions The results of the study suggest that the effect of atorvastatin therapy on thyroid autoimmunity depends on vitamin D status.

Key words

25-hydroxyvitamin D - thyroid autoimmunity - statins - vitamin D status
 

  • References

  • 1 Lewis SJ. Lipid-lowering therapy: Who can benefit?. Vasc Health Risk Manag 2011; 7: 525-534
    PubMedGoogle Scholar
  • 2 Schaefer JR. Lipid management for the prevention of cardiovascular disease. Curr Pharm Des 2011; 17: 852-860
    CrossrefPubMedGoogle Scholar
  • 3 Sirtori CR. The pharmacology of statins. Pharmacol Res 2014; 88: 3-11
    CrossrefPubMedGoogle Scholar
  • 4 Scandinavian Simvastatin Survival Study Group . Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study Group. Lancet 1994; 344: 1383-1389
    PubMedGoogle Scholar
  • 5 Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet 2002; 360: 7-22
    CrossrefPubMedGoogle Scholar
  • 6 Khush KK, Waters DD, Bittner V. et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study. Circulation 2007; 115: 576-583
    CrossrefPubMedGoogle Scholar
  • 7 Ridker PM, Danielson E, Fonseca FA. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207
    CrossrefPubMedGoogle Scholar
  • 8 Dembowski E, Davidson MH. A review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev 2009; 29: 2-12
    CrossrefPubMedGoogle Scholar
  • 9 Lorini R, Gastaldi R, Traggiai C. et al. Hashimoto’s thyroiditis. Pediatr Endocrinol Rev 2003; 1 (Suppl. 02) 205-211
    PubMedGoogle Scholar
  • 10 Caturegli P, Kimura H, Rocchi R. et al. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007; 19: 44-48
    CrossrefPubMedGoogle Scholar
  • 11 Hiromatsu Y, Satoh H, Amino N. Hashimoto’s thyroiditis: History and future outlook. Hormones (Athens) 2013; 12: 12-18
    CrossrefPubMedGoogle Scholar
  • 12 Brown RS. Autoimmune thyroid disease: Unlocking a complex puzzle. Curr Opin Pediatr 2009; 21: 523-528
    CrossrefPubMedGoogle Scholar
  • 13 Wu X, Schott M, Liu C. et al. Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis. Horm Metab Res 2008; 40: 838-841
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Gullu S, Emral R, Bastemir M. et al. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. Eur J Endocrinol 2005; 153: 41-48
    CrossrefPubMedGoogle Scholar
  • 15 Krysiak R, Kowalcze K, Okopień B. The effect of statin therapy on thyroid autoimmunity in patients with Hashimoto's thyroiditis: A pilot study. Pharmacol Rep 2016; 68: 429-434
    CrossrefPubMedGoogle Scholar
  • 16 Krysiak R, Szkróbka W, Okopień B. Moderate-dose simvastatin therapy potentiates the effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto's thyroiditis and vitamin D insufficiency. Pharmacol Rep 2017; 70: 93-97
    PubMedGoogle Scholar
  • 17 Krysiak R, Gilowska M, Okopień B. Different cardiometabolic effects of atorvastatin in men with normal vitamin D status and vitamin D insufficiency. Clin Cardiol 2016; 39: 715-720
    CrossrefPubMedGoogle Scholar
  • 18 Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: Definition and evaluation of the TSH Index. Clin Endocrinol 2009; 71: 529-534
    CrossrefPubMedGoogle Scholar
  • 19 Dietrich JW, Landgrafe-Mende G, Wiora E. et al. Calculated parameters of thyroid homeostasis: Emerging tools for differential diagnosis and clinical research. Front Endocrinol (Lausanne) 2016; 7: 57
    PubMedGoogle Scholar
  • 20 Dietrich JW, Müller P, Schiedat F. et al. Nonthyroidal illness syndrome in cardiac illness involves elevated concentrations of 3,5-diiodothyronine and correlates with atrial remodeling. Eur Thyroid J 2015; 4: 129-137
    CrossrefPubMedGoogle Scholar
  • 21 Płudowski P, Karczmarewicz E, Bayer M. et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64: 319-327
    PubMedGoogle Scholar
  • 22 İşgüven P, Gündüz Y, Kılıç M. Effects of thyroid autoimmunity on early atherosclerosis in euthyroid girls with Hashimoto's thyroiditis. J Clin Res Pediatr Endocrinol 2016; 8: 150-156
    CrossrefPubMedGoogle Scholar
  • 23 Stamatelopoulos KS, Kyrkou K, Chrysochoou E. et al. Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto's thyroiditis: The effect of menopausal status. Thyroid 2009; 19: 857-862
    CrossrefPubMedGoogle Scholar
  • 24 Krysiak R, Okopień B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto'sthyroiditis. J Clin Endocrinol Metab 2011; 96: 2206-2215
    CrossrefPubMedGoogle Scholar
  • 25 Krysiak R, Okopień B. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis. Thromb Haemost 2012; 108: 973-980
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Altieri B, Muscogiuri G, Barrea L. et al. Des vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord 2017; 18: 335-334
    CrossrefPubMedGoogle Scholar
  • 27 Mazokopakis EE, Papadomanolaki MG, Tsekouras KC. et al. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis?. Hell J Nucl Med 2015; 18: 222-227
    PubMedGoogle Scholar
  • 28 Hansen KE, Johnson MG. An update on vitamin D for clinicians. Curr Opin Endocrinol Diabetes Obes 2016; 23: 440-444
    CrossrefPubMedGoogle Scholar
  • 29 Bu DX, Griffin G, Lichtman AH. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011; 22: 165-170
    CrossrefPubMedGoogle Scholar
  • 30 Calton EK, Keane KN, Newsholme P. et al. The impact of vitamin D levels on inflammatory status: A systematic review of immune cell studies. PLoS One 2015; 10: e0141770
    CrossrefPubMedGoogle Scholar
  • 31 Shen D, Xin SL, Chen C. et al. Effect of atorvastatin on expression of TLR4 and NF-κB p65 in atherosclerotic rabbits. Asian Pac J Trop Med 2013; 6: 493-496
    CrossrefPubMedGoogle Scholar
  • 32 Chen Y, Zhang J, Ge X. et al. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J Biol Chem 2013; 288: 19450-19458
    CrossrefPubMedGoogle Scholar
  • 33 Moghaddas F, Masters SL. Monogenic autoinflammatory diseases: Cytokinopathies. Cytokine 2015; 74: 237-246
    CrossrefPubMedGoogle Scholar
  • 34 Park J, Matralis AN, Berghuis AM. et al. Human isoprenoid synthase enzymes as therapeutic targets. Front Chem 2014; 2: 50
    PubMedGoogle Scholar
  • 35 Szybiński Z. Polish Council for Control of Iodine Deficiency Disorders . Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol 2012; 63: 156-160
    PubMedGoogle Scholar